ALS-Zentrum der Charité

für ALS und andere Motoneuronerkrankungen

Publikationen

Publikationen der ALS-Forschungsgruppe an der Charité

ALS-Phänotypen – Korrelation mit NfL, Progression und Prognose

Meyer T, Dreger M, Grehl T, Weyen U, Kettemann D, Weydt P,

Mehr ALS-Phänotypen – Korrelation mit NfL, Progression und Prognose

ALSFRS-R-SE – eine selbsterklärende Version der ALS-Funktionsskala für Patienten und professionelle Nutzer

Maier A, Boentert M, Reilich P, Witzel S, Petri S, Großkreutz J,

Mehr ALSFRS-R-SE – eine selbsterklärende Version der ALS-Funktionsskala für Patienten und professionelle Nutzer

Neurofilament light chain response during therapy with antisense oligonucleotide Tofersen in SOD1-related ALS – treatment experience in clinical practice

Meyer T, Schumann P, Weydt P, Petri S, Koc Y, Spittel S,

Mehr Neurofilament light chain response during therapy with antisense oligonucleotide Tofersen in SOD1-related ALS – treatment experience in clinical practice

Neurofilament light chain (NfL) – Biomarker für die ALS-Progression

Meyer T, Salkic E, Grehl T, Weyen U, Kettemann D, Weydt P,

Mehr Neurofilament light chain (NfL) – Biomarker für die ALS-Progression

Der Einsatz von Patient-reported Outcome Measures (PROM) und die Perspektive digitaler Biomarker bei der Amyotrophen Lateralsklerose

Maier A, Münch C, Meyer T. Klinische Neurophysiologie 2023; 54(01): 28-34. doi:

Mehr Der Einsatz von Patient-reported Outcome Measures (PROM) und die Perspektive digitaler Biomarker bei der Amyotrophen Lateralsklerose

Acceptance of Enhanced Robotic Assistance Systems in People With Amyotrophic Lateral Sclerosis-Associated Motor Impairment: Observational Online Study

Maier A, Eicher C, Kiselev J, Klebbe R, Greuèl M, Kettemann D,

Mehr Acceptance of Enhanced Robotic Assistance Systems in People With Amyotrophic Lateral Sclerosis-Associated Motor Impairment: Observational Online Study

1 2 3 4 5 … 8

Publikationen mit Beteiligung der ALS-Forschungsgruppe an der Charité

PGC-1α is a male-specific disease modifier of human and experimental amyotrophic lateral sclerosis

Eschbach J, Schwalenstöcker B, Soyal SM,

Mehr PGC-1α is a male-specific disease modifier of human and experimental amyotrophic lateral sclerosis

Optical coherence tomography does not support optic nerve involvement in amyotrophic lateral sclerosis

Roth NM, Saidha S, Zimmermann H,

Mehr Optical coherence tomography does not support optic nerve involvement in amyotrophic lateral sclerosis

The dynactin p150 subunit: cell biology studies of sequence changes found in ALS/MND and Parkinsonian syndromes

Stockmann M, Meyer-Ohlendorf M, Achberger K,

Mehr The dynactin p150 subunit: cell biology studies of sequence changes found in ALS/MND and Parkinsonian syndromes

A novel optineurin truncating mutation and three glaucoma-associated missense variants in patients with familial amyotrophic lateral sclerosis in Germany

Weishaupt JH, Waibel S, Birve A,

Mehr A novel optineurin truncating mutation and three glaucoma-associated missense variants in patients with familial amyotrophic lateral sclerosis in Germany

Truncating mutations in FUS/TLS give rise to a more aggressive ALS-phenotype than missense mutations: a clinico-genetic study in Germany

Waibel S, Neumann M, Rosenbohm A,

Mehr Truncating mutations in FUS/TLS give rise to a more aggressive ALS-phenotype than missense mutations: a clinico-genetic study in Germany

A randomized, double blind, placebo-controlled trial of pioglitazone in combination with riluzole in amyotrophic lateral sclerosis

Dupuis L, Dengler R, Heneka MT,

Mehr A randomized, double blind, placebo-controlled trial of pioglitazone in combination with riluzole in amyotrophic lateral sclerosis

NIPA1 polyalanine repeat expansions are associated with amyotrophic lateral sclerosis

Blauw HM, van Rheenen W, Koppers

Mehr NIPA1 polyalanine repeat expansions are associated with amyotrophic lateral sclerosis

Ataxin-2 intermediate-length polyglutamine expansions in European ALS patients

Lee T, Li YR, Ingre C,

Mehr Ataxin-2 intermediate-length polyglutamine expansions in European ALS patients

A large genome scan for rare CNVs in amyotrophic lateral sclerosis

Blauw HM, Al-Chalabi A, Andersen PM,

Mehr A large genome scan for rare CNVs in amyotrophic lateral sclerosis

Novel missense and truncating mutations in FUS/TLS in familial ALS

Waibel S, Neumann M, Rabe M,

Mehr Novel missense and truncating mutations in FUS/TLS in familial ALS

Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis

van Es MA, Veldink JH, Saris

Mehr Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis

No evidence of association of FLJ10986 and ITPR2 with ALS in a large German cohort

Fernández-Santiago R, Sharma M, Berg D,

Mehr No evidence of association of FLJ10986 and ITPR2 with ALS in a large German cohort

1 2 3 4